A Randomized, Double-Blind, Placebo-Controlled Study of

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled Study of SD-809 (Dutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia - Protocol SD-809-C-18
StatusFinished
Effective start/end date6/1/146/30/15

Funding

  • AUSPEX PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.